Twin Tree Management, LP Sarepta Therapeutics, Inc. Put Options Transaction History

Twin Tree Management, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $14 Million - $17.7 Million	113,000 Added 110.03%	215,700 $26.9 Million
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $11.6 Million - $16.8 Million	102,700 New	102,700 $16.2 Million
Q2 2020 Aug 12, 2020	SELL	$93.0 - $171.7 $9.5 Million - $17.5 Million	-102,100 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $980,322 - $1.57 Million	-11,900 Reduced 10.44%	102,100 $9.99 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $8.3 Million - $17.9 Million	114,000 New	114,000 $8.59 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.